92 related articles for article (PubMed ID: 10729660)
1. Clinical features and in vitro susceptibilities of two varieties of Cryptococcus neoformans in Taiwan.
Chen YC; Chang SC; Shih CC; Hung CC; Luhbd KT; Pan YS; Hsieh WC
Diagn Microbiol Infect Dis; 2000 Mar; 36(3):175-83. PubMed ID: 10729660
[TBL] [Abstract][Full Text] [Related]
2. Correlation of antifungal susceptibility and sequence types within Cryptococcus neoformans VNI from HIV patients, and ERG11 gene polymorphism.
Bive BZ; Sacheli R; Mudogo CN; Zakayi PK; Bontems S; Lelo GM; Hayette MP
J Mycol Med; 2023 Nov; 33(4):101428. PubMed ID: 37651769
[TBL] [Abstract][Full Text] [Related]
3. Temporal trends in antifungal susceptibility of Cryptococcus neoformans isolates from a reference laboratory in the United States, 2011-2021.
Ordaya EE; Abu Saleh OM; Vergidis P; Deml SM; Wengenack NL; Fida M
Mycoses; 2024 Jan; 67(1):e13691. PubMed ID: 38214377
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of the verapamil and amphotericin B against Cryptococcus neoformans.
Pereira TC; do Carmo PHF; de Menezes RT; de Oliveira HC; de Oliveira LD; Junqueira JC; Scorzoni L
Folia Microbiol (Praha); 2023 Dec; 68(6):999-1004. PubMed ID: 37950840
[TBL] [Abstract][Full Text] [Related]
5. ATI-2307 Exhibits Equivalent Antifungal Activity in
Gerlach ES; Altamirano S; Yoder JM; Luggya TS; Akampurira A; Meya DB; Boulware DR; Rhein J; Nielsen K
Front Cell Infect Microbiol; 2021; 11():695240. PubMed ID: 34249782
[TBL] [Abstract][Full Text] [Related]
6. Cryptococcosis caused by cryptococcus gattii: 2 case reports and literature review.
Xue X; Deng H; Zhao L; Zang X; Asuquo IP; Meng M; Ma X; Qin C; Meng Y; Wu C; Gao J; Pan L
Medicine (Baltimore); 2020 Dec; 99(50):e23213. PubMed ID: 33327239
[TBL] [Abstract][Full Text] [Related]
7. The status of cryptococcosis in Latin America.
Firacative C; Lizarazo J; Illnait-Zaragozí MT; Castañeda E;
Mem Inst Oswaldo Cruz; 2018; 113(7):e170554. PubMed ID: 29641639
[TBL] [Abstract][Full Text] [Related]
8. Variability in innate host immune responses to cryptococcosis.
Garelnabi M; May RC
Mem Inst Oswaldo Cruz; 2018; 113(7):e180060. PubMed ID: 29668826
[TBL] [Abstract][Full Text] [Related]
9. Flucytosine resistance in Cryptococcus gattii is indirectly mediated by the FCY2-FCY1-FUR1 pathway.
Vu K; Thompson GR; Roe CC; Sykes JE; Dreibe EM; Lockhart SR; Meyer W; Engelthaler DM; Gelli A
Med Mycol; 2018 Oct; 56(7):857-867. PubMed ID: 29554336
[TBL] [Abstract][Full Text] [Related]
10. Models for Inducing Experimental Cryptococcosis in Mice.
Castro-Lopez N; Wormley FL
Methods Mol Biol; 2024; 2775():29-46. PubMed ID: 38758309
[TBL] [Abstract][Full Text] [Related]
11. Three phylogenetic groups have driven the recent population expansion of Cryptococcus neoformans.
Ashton PM; Thanh LT; Trieu PH; Van Anh D; Trinh NM; Beardsley J; Kibengo F; Chierakul W; Dance DAB; Rattanavong S; Davong V; Hung LQ; Chau NVV; Tung NLN; Chan AK; Thwaites GE; Lalloo DG; Anscombe C; Nhat LTH; Perfect J; Dougan G; Baker S; Harris S; Day JN
Nat Commun; 2019 May; 10(1):2035. PubMed ID: 31048698
[TBL] [Abstract][Full Text] [Related]
12. In vitro effects of selective serotonin reuptake inhibitors on Cryptococcus gattii capsule and biofilm.
Viveiro LRDG; Rehem AR; Santos ELS; Carmo PHFD; Junqueira JC; Scorzoni L
Pathog Dis; 2024 Feb; 82():. PubMed ID: 38204138
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous cryptococcosis simulating pyoderma gangrenosum.
Oppenheimer AR; Valente NYS; Silva DHM
Rev Soc Bras Med Trop; 2020; 53():e20200120. PubMed ID: 32556041
[No Abstract] [Full Text] [Related]
14. Usual Presentation Of An Unusual Pathogen - Cryptococcus Laurentii Meningitis: A Case Report.
Zulfiqar A; Irfan R; Hanif F; Usman J
J Pak Med Assoc; 2023 Oct; 73(10):2100-2102. PubMed ID: 37876081
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids, COVID-19 and Cryptococcosis.
Dos Santos WM; Rogerio AP
Antiinflamm Antiallergy Agents Med Chem; 2023; 22(2):67-70. PubMed ID: 37702231
[TBL] [Abstract][Full Text] [Related]
16. A case report of cryptococcosis in a captive Cape hyrax (Procavia capensis).
Sedghi Masoud N; Iwaide S; Kobayashi N; Nakagawa D; Orito M; Iwahashi N; Murakami T
J Vet Med Sci; 2024 Jun; 86(6):619-622. PubMed ID: 38631871
[TBL] [Abstract][Full Text] [Related]
17. Fungicide-tolerant persister formation during cryptococcal pulmonary infection.
Ke W; Xie Y; Chen Y; Ding H; Ye L; Qiu H; Li H; Zhang L; Chen L; Tian X; Shen Z; Song Z; Fan X; Zong JF; Guo Z; Ma X; Xiao M; Liao G; Liu CH; Yin WB; Dong Z; Yang F; Jiang YY; Perlin DS; Chen Y; Fu YV; Wang L
Cell Host Microbe; 2024 Feb; 32(2):276-289.e7. PubMed ID: 38215741
[TBL] [Abstract][Full Text] [Related]
18.
Alobaidi D; Mahgoub AE; Bachuwa G; Osterholzer D
BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35787508
[TBL] [Abstract][Full Text] [Related]
19. Survival after cryptococcosis in Germany: A retrospective multicenter cohort study of patients diagnosed between 2004 and 2021.
Kessel J; Rossaert AC; Lingscheid T; Grothe J; Harrer T; Wyen C; Tominski D; Bollinger T; Kehr AK; Kalbitz S; Hoffmann C; Cornely O; Koppe U; Stephan C; Rickerts V
Int J Med Microbiol; 2024 Mar; 314():151614. PubMed ID: 38368645
[TBL] [Abstract][Full Text] [Related]
20. Cryptococcosis in non-human immunodeficiency virus-infected patients: A clinical dilemma and diagnostic enigma.
Paul M; Bhatia M; Rohilla R; Sasirekha U; Kaistha N
Indian J Med Microbiol; 2020; 38(2):229-234. PubMed ID: 32883941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
